Thermo Fisher Scientific: Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll
Thermo Fisher cut its 2025 EPS and revenue outlook due to tariffs and U.S. policy changes, expecting a $400 million sales hit and lower operating income. read more
Read full article »
Thermo Fisher is a Massachusetts-based biotech firm that manufactures products such as reagents and scientific instruments for sectors including forensics and pharmaceuticals.
Read more